Skip to main content
. 2019 Sep 4;9:12724. doi: 10.1038/s41598-019-49215-9

Table 2.

PD-L1 positivity in tumor cells versus tumor-infiltrating immune cells of different salivary gland carcinomas (n = 167).

Tumor cells
PD-L1 negative (n = 139) PD-L1 positive (n = 28)
Tumor-infiltrating immune cells PD-L1 negative (n = 133) 122 (73.0%) 11 (6.6%)
PD-L1 positive (n = 34) 17 (10.2%) 17 (10.2%)